Business
Sareum to Present at London Investor Show
Sareum to Present at London Investor Show.
About this update from Sareum Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 3587R Sareum Holdings PLC 25 October 2013 \n \n\nAIM:SAR 25 October 2013 \n \nSAREUM HOLDINGS PLC\n(\"Sareum\" or \"the Company\") \nSareum to Present at London Investor Show and at BIO Europe\nSareum (AIM: SAR), the specialist cancer drug discovery and development business, is pleased to announce that CEO Dr Tim Mitchell will present an update of Sareum's progress at the London Investor Show, which takes place at Olympia, London, today. \nDr Mitchell will also make a more detailed presentation on Sareum's research programmes at BIO-Europe, which is being held in Vienna, Austria, on Tuesday 5 November. BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry.\nSareum's CEO, Dr Tim Mitchell, commented: \"These exciting events offer us ideal opportunities to present our latest developments to both investors and our industry peers.\"\n\n\n\n\nSareum Holdings plc\n\n\n \n\n\n\n\nTim Mitchell\n\n\n01223 497 700\n\n\n\n\nSanlam Securities UK Limited (Nomad)\n\n\n\n\nSimon Clements\n\n\n020 7628 2200\n\n\n\n\nHybridan LLP (Broker)\n\n\n \n\n\n\n\nClaire Noyce, William Lynne\n\n\n020 7947 4350 / 020 7947 4361\n\n\n\n\nMedia enquiries:\n\n\n \n\n\n\n\nThe Communications Portfolio Ltd\n\n\n \n\n\n\n\nAriane Comstive\[email protected]\n\n\n020 7536 2026\n\n\n\n\n \nNotes for editors: \nAbout Sareum Holdings plc\nSareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on cancer and auto-immune disease. Sareum aims to successfully deliver drug candidates for licencing to pharmaceutical and biotechnology companies at the pre-clinical ...